Page 1 World Health Organization UPDATED RECOMMENDATIONS ON TREATMENT OF
ADOLESCENTS AND CHILDREN WITH CHRONIC HCV INFECTION, AND HCV SIMPLIFIED …

Introduction Progress toward hepatitis C virus (HCV) elimination is impeded by low testing
and treatment due to the current diagnostic pathway requiring multiple visits leading to loss …

An estimated 2.4 million people in the United States are living with hepatitis C virus (HCV)
infection. In 2020, the Centers for Disease Control and Prevention updated hepatitis C …

Abstract Background In Catalonia (Spain), people who inject drugs (PWID) face numerous
barriers to access to mainstream healthcare services for hepatitis C confirmatory diagnosis …

Abstract Background and Aims The World Health Organization recently called for the
elimination of hepatitis C virus (HCV) and has identified people who inject drugs (PWID) as …

Background Although novel hepatitis C virus (HCV) RNA point‐of‐care technology has the
potential to enhance the diagnosis in resource‐limited settings, very little real‐world …

Background Injecting drug use is a major driver of hepatitis C virus (HCV) spread worldwide,
and the World Health Organization (WHO) has identified people who inject drugs (PWID) as …

Dried blood spots (DBS) are a reliable tool to diagnose viremic hepatitis C virus (HCV)
infection. We evaluated the clinical performance of a DBS‐based molecular assay for the …

The current multiday diagnosis and treatment paradigm for hepatitis C virus (HCV) infection
results in far fewer patients receiving treatment with direct-acting antiviral agents than those …

Despite remarkable therapeutic advances, hepatitis C virus (HCV) infection continues to be
a major global problem. While the development of highly effective direct-acting antivirals has …